|
| |
| | | 69428 | | 25.09.2024 | | GlaxoSmithKline AG | | | | | | | 24.09.2029 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Omjjara 100 mg | Filmtabletten | Coated tablets (Momelotinibum 100 mg) | L01EJ04 | CI | | 02 | Omjjara 150 mg | Filmtabletten | Coated tablets (Momelotinibum 150 mg) | L01EJ04 | CI | | 03 | Omjjara 200 mg | Filmtabletten | Coated tablets (Momelotinibum 200 mg) | L01EJ04 | CI |
|
|
|
